FCM
CYTK icon

Flinton Capital Management’s Cytokinetics CYTK Stock Holding History

Flinton Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$178K Hold
15,606
– – 0.01% 685
2019
Q2 		$176K Hold
15,606
– – 0.01% 706
2019
Q1 		$126K Buy
15,606
+5,134
+49% +$37.7K ﹤0.01% 741
2018
Q4 		$66K Buy
10,472
+3,740
+56% +$27.4K ﹤0.01% 783
2018
Q3 		$66K Buy
6,732
+3,162
+89% +$25.4K ﹤0.01% 819
2018
Q2 		$30K Buy
+3,570
New +$29.7K ﹤0.01% 830

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Flinton Capital Management's CYTK Position: Q3 2019 in Review

Flinton Capital Management held its Cytokinetics (CYTK) position steady in Q3 2019 at 15,606 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #685.

Flinton Capital Management first reported a position in CYTK in Q2 2018 and has held it in 6 quarters since. 148 funds tracked by Wall St. Rank hold CYTK as of Q3 2019.

  • Flinton Capital Management held 15,606 shares of Cytokinetics worth $178K as of Q3 2019.
  • Flinton Capital Management left its Cytokinetics share count unchanged in Q3 2019.
  • Cytokinetics made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #685 holding.
  • Flinton Capital Management first reported a position in Cytokinetics in Q2 2018 and has held it in 6 quarters since.
  • 148 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.